• Monday, July 22, 2024
businessday logo


UCH establishes vitamin mineral infusion clinic


The University College Hospital (UCH) Ibadan, has established a clinic where multi-vitamins and minerals will be used to boost the health of patients having terminal and chronic diseases.

Temitope  Alonge, the Chief Medical Director of the UCH, made this disclosure in an interview with the News Agency of Nigeria (NAN) in  Ibadan on Sunday.

Alonge said that UCH was a pioneer hospital to start such a clinic in West Africa, adding that “it will run the clinic in partnership with ActivLife Infusion Clinic, based in the UK”.

He said the clinic would primarily use vitamins and mineral infusions on patients whose body immune systems had collapsed or was weak.

According to him, patients suffering from terminal illnesses like cancer, stroke and geriatric will benefit most from the services of the clinic.

“The clinic will be run by a Nutrition Support Team made up of a doctor and two nurses trained in nutrition medicine and a laboratory has been created for micro-nutrients supply generally.

“We are able to do this through partnership with ActivLife Infusion Company based in the UK,” he said.

The Chief Executive Officer of ActivLife Infusion Clinic in Nigeria, Bunmi Talabi-Adeyemi, a certified Tropical Nurse, said the establishment of the clinic was the first attempt to spread the activities of the company to South west zone.

Adeyemi said a lot of research findings had proved that the infusion of vitamin minerals into the body could boost immune systems of patients whose immune systems had collapsed.

“In chronic illnesses the intestines are often inflamed; they fail to absorb important vitamins and minerals efficiently.

“This often leads to low levels of nutrients in the tissues even when dietary supplements and nutritional diets should be providing optimal nutrients,” she said.

Adeyemi said the clinic would serve those who needed adequate vitamin mineral supplement as well as patients suffering from terminal diseases like cancer.